International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1323-1329 , 1 August 2006

The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy

  • Ernst J. Smid, M.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • T. Rianne Stoter, B.Sc.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Elisabeth Bloemena, M.D., Ph.D.

      Affiliations

    • Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
    • Department of Oral and Maxillofacial Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • M. Vincent M. Lafleur, Ph.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • C. René Leemans, M.D., Ph.D.

      Affiliations

    • Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Isaac van der Waal, S.D.D., Ph.D.

      Affiliations

    • Department of Oral and Maxillofacial Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Ben J. Slotman, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Johannes A. Langendijk, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands
    • Corresponding Author InformationReprint requests to: J. A. Langendijk, M.D., Ph.D., Department of Radiation Oncology, University Medical Center Groningen, PO Box 30001, 9300 RB Groningen, The Netherlands. Tel: (+31) 50-3611190; Fax: (+31) 50-3611692

Received 13 January 2006 ,Revised 17 February 2006 ,Accepted 4 March 2006.

References 

  1. Bastit L , Blot E , Debourdeau P , et al.   Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers . Int J Radiat Oncol Biol Phys . 2001;49:139–146
  2. Chen TY , Emrich LJ , Driscoll DL . The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma . Int J Radiat Oncol Biol Phys . 1987;13:833–837
  3. Amdur RJ , Parsons JT , Mendenhall WM , et al.   Postoperative irradiation for squamous cell carcinoma of the head and neck (An analysis of treatment results and complications) . Int J Radiat Oncol Biol Phys . 1989;16:25–36
  4. Mantravadi RV , Haas RE , Liebner EJ , et al.   Postoperative radiotherapy for persistent tumor at the surgical margin in head and neck cancer . Laryngoscope . 1983;93:1337–1340
  5. O’Brien CJ , Smith JW , Soong SJ , et al.   Neck dissection with and without radiotherapy (Prognostic factors, patterns of recurrence and survival) . Am J Surg . 1986;152:456–463
  6. Parsons JT , Mendenhall WM , Stringer SP , et al.   An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity . Int J Radiat Oncol Biol Phys . 1997;39:137–148
  7. Leemans CR , Tiwari R , van der Waal I , et al.   The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts . Laryngoscope . 1990;100:1194–1198
  8. Carter RL , Bliss JM , Soo KC , et al.   Radical neck dissections for squamous carcinomas (Pathological findings and their clinical implications with particular reference to transcapsular spread) . Int J Radiat Oncol Biol Phys . 1987;13:825–832
  9. Bartelink H , Breur K , Hart G , et al.   The value of postoperative radiotherapy as an adjuvant to radical neck dissection . Cancer . 1983;52:1008–1013
  10. Johnson JT , Barnes EL , Myers EN , et al.   The extracapsular spread of tumor cervical node metastasis . Arch Otolaryngol . 1981;107:725–729
  11. Leemans CR , Tiwari R , Nauta JJ , et al.   Recurrence at the primary site in head and neck cancer and the significance of neck node metastases as a prognostic factor . Cancer . 1993;73:187–190
  12. Fagan JJ , Collins B , Barnes L , et al.   Perineural invasion in squamous cell carcinomas of the head and neck . Arch Otolaryngol Head Neck Surg . 1998;124:637–640
  13. Soo KC , Carter RL , O’Brien CJ , et al.   Prognostic implications of perineural spread in squamous carcinomas of the head and neck . Laryngoscope . 1986;96:1145–1148
  14. Hirsch FR , Varella-Garcia M , Bunn PA , et al.   Epidermal growth factor receptor in non–small-cell lung carcinomas (Correlation between gene copy number and protein expression and impact on prognosis) . J Clin Oncol . 2003;21:3798–3807
  15. Hirsch FR , Scagliotti GV , Langer CJ , et al.   Epidermal growth factor family of receptors in preneoplasia and lung cancer (Perspectives for targeted therapies) . Lung Cancer . 2003;41(Suppl. 1):S29–S42
  16. Moscatello DK , Holgado-Madruga M , Godwin AK , et al.   Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors . Cancer Res . 1995;55:5536–5539
  17. Prenzel N , Fischer OM , Streit S , et al.   The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification . Endocr Relat Cancer . 2001;8:11–31
  18. Prenzel N , Zwick E , Daub H , et al.   EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF . Nature . 1999;402:884–888
  19. Liu D , Aguirre Ghiso J , Estrada Y , et al.   EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma . Cancer Cell . 2002;1:445–457
  20. Dassonville O , Formento JL , Francoual M , et al.   Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer . J Clin Oncol . 1993;11:1873–1878
  21. Hermanek P , Sobin LH . In: TNM atlas (Illustrated guide to the TNM/pTNM classification of malignant tumours) . 4th ed.. Berlin, Germany: Springer Verlag; 1997;p. 13–21
  22. Ang KK , Berkey BA , Tu X , et al.   Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma . Cancer Res . 2002;62:7350–7356
  23. Wen QH , Miwa T , Yoshizaki T , et al.   Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy . Laryngoscope . 1996;106:884–888
  24. Ma BB , Poon TC , To KF , et al.   Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma—a prospective study . Head Neck . 2003;25:864–872
  25. Chua DT , Nicholls JM , Sham JS , et al.   Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy . Int J Radiat Oncol Biol Phys . 2004;59:11–20
  26. Grandis JR , Melhem MF , Gooding WE , et al.   Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival . J Natl Cancer Inst . 1998;90:824–832
  27. Eriksen JG , Steiniche T , Overgaard J . The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study . Radiother Oncol . 2005;74:93–100
  28. Bentzen SM , Atasoy BM , Daley FM , et al.   Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial . J Clin Oncol . 2005;23:5560–5567
  29. Schmidt-Ullrich KR , Mikkelsen RB , Dent P , et al.   Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation . Oncogene . 1997;15:1191–1197
  30. Sturla LM , Amorino G , Alexander MS , et al.   Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2 . J Biol Chem . 2005;280:14597–14604
  31. Overgaard J , Hansen HS , Specht L , et al.   Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck (DAHANCA 6 and 7 randomised controlled trial) . Lancet . 2003;362(9388):933–940
  32. Fu KK , Pajak TF , Trotti A , et al.   A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas (First report of RTOG 9003) . Int J Radiat Oncol Biol Phys . 2000;48:7–16
  33. Ang KK , Trotti A , Brown BW , et al.   Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer . Int J Radiat Oncol Biol Phys . 2001;51:571–578
  34. Awwad HK , Lotayef M , Shouman T , et al.   Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer (Influence of proliferation) . Br J Cancer . 2002;86:517–523
  35. Langendijk JA , de Jong MA , Leemans CR , et al.   Postoperative radiotherapy in squamous cell carcinoma of the oral cavity (The importance of the overall treatment time) . Int J Radiat Oncol Biol Phys . 2003;57:693–700
  36. Sanguineti G , Richetti A , Bignardi M , et al.   Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer (Results of a multicenter Phase III study) . Int J Radiat Oncol Biol Phys . 2005;61:762–771
  37. Bonner JA , Giralt J , Harari PM , et al.   Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck (A phase II study of high dose radiation therapy with or without cetuximab [Abstract]) . J Clin Oncol . 2004;22(14 Suppl):5507

PII: S0360-3016(06)00420-2

doi: 10.1016/j.ijrobp.2006.03.011

International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1323-1329 , 1 August 2006

Article Tools

* Image Usage & Resolution